A method for the separation and quantification of a complex ganglioside mixture from a clinically available amount (5 ml) of human cerebrospinal fluid (CSF) is described. After reduction of the CSF volume by ultrafiltration, gangliosides are extracted with methanol/chloroform, then separated and quantified by high performance thin layer chromatography (HPTLC) and direct densitometry. For purification of crude ganglioside extract, the method of choice was microdialysis against water. Recovery for the present method including all methodological steps was 78%. No delective loss of gangliosides was demonstrated.
Introduction
, ,^ " " , ,,.,,,. onstrated (3) . So far, only a few published studies The content of lipids in cerebrospinal fluid (CSF) is have shown that the ganglioside profile of CSF more very low (1) . Gangliosides 1 ) are sialic acid-containing closely resembles that of brain tissue than that of glycosphingolipids displaying their highest concentra-plasma (4 -6) . However, due to methodological diftions in nervous tissue (2) . Their accumulation in CSF ficulties, the gangliosides in normal human CSF were in lipid storage diseases (gangliosidosis) has been dem-not clearly identified in these previous reports. Quantification of gangliosides in the picomolar range using *) See page 864.
scanning densitometry on high-performance thin-layer chromatography (HPTLC) has been reported (7, 8) . The aim of this study was to present a method suitable for simultaneous profile analysis and ganglioside quantification from clinically available amounts of CSF (5 ml). The method consisted of ganglioside extraction, separation and quantification, employing HPTLC on silica gel and scanning densitometry.
Materials and Methods
All reagents were of reagent-grade quality. Solvents were redistilled before used. A commercially available apparatus from Sartorius GmbH (G ttingen, FRG) and collodium bags SM 13200, were used for ultraflltration. Sephadex G-25 fine was purchased from Pharmacia Fine Chemicals (Uppsala, Sweden). Standard dialysis membranes from Technicon Chemicals Co.
(Orcq, Belgium) were used for dialysis. High-performance thinlayer Chromatographie plates (HPTLC) silica gel 60 (10 χ 10 cm) were purchased from Merck (Darmstadt, FRG). The Cronassial ganglioside mixture from Fidia (Abano Terme, Italy), diluted 1:10 with water (0.5 g per litre of gangliosides) was used as a standard for the ganglioside HPTLC determination. (19) . ** Neu Ac = 7V-Acetylneuraminic acid; Lac = lactose; GgOse 4 = gangliotetraose = Gal( l -3)GalNAc( l -4)Gal( l -4)GlcCer; Cer = Cer amide. The location of the NeuAc residue is indicated by a Roman numeral designating the position of the monosaccharide residue in the parent oligosaccharide (counting from the ceramide end) to which the NeuAc residue is attached, with an Arabic numeral superscript indicating the position within that residue to which the NeuAc is attached (20) .
before ganglioside extraction (2000 g, 10 minutes). Pooled 'normal' CSFs were used for method evaluation and statistical analysis. Recovery was measured in two ways, i. e. either with CSF itself using a radiolabelled tracer ([   3   H ]G Dla , 5 μg/5 ml CSF), or by processing the Cronassial ganglioside mixture in H 2 O or artificial CSF (7 μg/5 ml CSF art.). Artificial CSF consisted of CSF ultrafiltrate (5 ml) and serum (20 μΐ). Assay precision was evaluated by analysing pooled CSF (or Cronassial added to artificial CSF) twelve times on the same day and on different days in a period of four mounths. Linearity of the relationship between densitometric responses (total area) and ganglioside content was determined by spotting increasing amounts of gangliosides from diluted Cronassial on HPTLC plates.
Ultrafiltration (vacuum dialysis)
Native CSF samples (5 ml) were reduced to about 0.5 ml by ultraflltration against water, the semipermeable membrane rinsed with 0.250 ml of 0.077 mol/1 saline and the volume of the CSF concentrate adjusted to 0.750 ml.
CSF ganglioside extraction procedure
Gangliosides were extracted from CSF by a slightly modified method of Svennerholm & Fredman (9) . In place of the water phase, a reduced volume of CSF (concentrate) was used. The ratio chloroform-methanol-CSF was 1:2:0.75 by volume. Briefly, 2 ml of methanol were added to 0.75 ml of CSF concentrate; after mixing on a cyclomixer, 1 ml of chloroform was added and mixed again. The gangliosides were separated from other lipids by phase partition, after the addition of 0.65 ml of water. The two phases were separated by centrifugation (15 -20 min, 3000 g), and the upper phase was set aside. For secondphase partition of the lower phase, 0.380 ml of methanol and 0.250 ml of water were added. The two upper phases were combined and evaporated to dryness (37 °C).
Alternative procedure for CSF ganglioside extrac tion Gangliosides were directly extracted from 6 ml of native CSF, using a solvent ratio of chloroform-methanol-CSF of 8:16:6 by volume. For phase partition, 5.2 ml of water were added. After overnight separation in a glass funnel, the upper phase was set aside. For second-phase partition of the lower phase, 3 ml of methanol and 2 ml of water were added. The two upper phases were combined and evaporated to dryness (37 °C).
Purification of crude ganglioside extract by microdi alysis
Crude ganglioside extract was dissolved in a few microlitres of chloroform-methanol-water (60:30:4.5, by volume) and quantitatively transferred to a microcup (0.1 ml) for dialysis. After evaporation of the solvent to dryness, the ganglioside residue was dissolved in 100 μΐ of water and the microcup covered with a dialysis membrane. After dialysis against water for about four hours, the dialysis membrane was pierced with the plastic tip of a 100 μΐ micropipette, and the ganglioside water extract quantitatively transferred to a conical tube and evaporated to dryness.
Alternative procedure for purification of crude ganglioside extract by gel filtration on Sephadex G-25. A modified method of Wells and Dittmer (10) Crude ganglioside extract was dissolved in chloroform-methanol-water (60:30:4.5, by volume) and applied to a Sephadex G-25 column (110 χ 5mm, 1.4 ml bed volume, resin mixed with the same solvent mixture). The gangliosides were eluted from the column with 6 -7 ml of the same solvent mixture. The column was then eluted with about 1 ml of the second solvent mixture of chloroform-methanol-water (20:20:7.5, by volume), and the combined eluates were evaporated to dryness.
High performance thin-layer chromatography (HPTLC) Gangliosides were separated using the ascending "sandwich" HPTLC technique (11) . Two plastic 1 mm-thick strips were used as gaskets. Before use, HPTLC plates were pre-washed with chloroform-methanol (1:1, by volume) and activated at 110 °C during 60 min. The ganglioside extract was dissolved in a few microlitres of chloroform-methanol-water (60:30:4.5, by volume) and quantitatively transferred onto a HPTLC plate. The samples were applied as a line. After formation of a "sandwich" the following solvent system was used for Chromatographie separation of gangliosides: chloroform-methanol-12 mmol/1 MgCl 2 in H 2 O-13.3 mol/1 NH 3 (60:40:9:0.5, by volume). Chromatography was performed at 17 -18 °C using a freshly prepared solvent system. Development was stopped when the solvent front reached 1 -1.5 cm from the upper edge of the plate. After drying the HPTLC plate, the same procedure was repeated with a fresh solvent mixture.
Densitometric scanning and quantification of CSF gangliosides
For densitometric quantification, three standards of 5, 10 and 15 μΐ of diluted Cronassial (corresponding to 2.5, 5 and 7.5 μg of gangliosides, respectively) were spotted on the same HPTLC plate. Gangliosides were visualized on the plate (as lipid-bound NeuAc) by spraying with resorcinol-HCl reagent diluted with an equal volume of water (12) , and the HPTLC plate was heated as suggested by Ando et al. (13) . Total amounts of CSF gangliosides were calculated from a calibration curve plotted from the densitometric response (total area) as a function of the amount of gangliosides ^g) in standards (Cronassial). The content of individual ganglioside was calculated from the calibration curve based on an appropriate densitometric response (area) or from the relative percentage multiplied by the total content of gangliosides.
Results and Discussion
Procedure of CSF ganglioside extraction Reduction of the CSF and solvent volumes increased the recovery and reproducibility of the extraction method (tab. 1). Ultrafiltration did not result in either any major loss of total gangliosides (tab. 1) or any selective loss (tab. 2), although the molecules involved were those of low molecular mass. The procedure is based on the assumption that CSF gangliosides are associated with proteins. Albumin is known to strongly bind to gangliosides (14) . Moreover, a rapid procedure of CSF volume reduction causes an abrupt increase in ganglioside concentration, thereby triggering the formation of micelles of higher molecular mass (2) .
Ultrafiltration also removes large quantities of salts (especially divalent cations) from the CSF before extraction of the gangliosides (CSF contains about 270 mmol/1 salts and 300 nmol/1 gangliosides). A tendency of gangliosides to accumulate into a 'gangliosideprotein-divalent cation complex' at the interface in the biphasic solvent system has been described (15) .
We also investigated whether this ganglioside isolation procedure, based on the partitioning method, is applicable in the present CNS pathology where less polar gangliosides (i.e. G M 2 gangliosidosis) are elevated. About 75% of G M2 was recovered in the upper organic phase after adding G M 2 ganglioside to a CSF sample ( fig. 3e ).
In pathological CSF samples with high protein concentrations, the concentration of polysialogangliosides, particularly G Qlb , is decreased (tab. 3), but a similar effect was also demonstrated 'in vitro' by adding serum to CSF samples (tab. 3, fig. 1 ). A dramatic decrease in the concentration of polysialogangliosides (G Qlb about 75%, G Tlb and G D i b about 50%) was also observed after the addition of crude CSF ganglioside extract to serum, as determined by ganglioside extraction and HPTLC (figs. 3g, f)· In contrast, a parallel experiment using isolated gangliosides of CSF and serum gave a strictly additive HPTLC analysis upon mixing ( fig. 1 ). This means that high protein concentrations markedly interfere with the extraction of gangliosides. The action of serum sialidase as a possible cause of the decrease of ganglioside values was ruled out by replacing serum with pure albumin solution ( fig. 1) . Therefore, for the analysis of pathological CSFs with high protein concentration should be reduced less and the volume of organic solvents proportionally increased, allowing efficient protein precipitation and ganglioside extraction. The question remains, however, as to the nature of the real ganglioside pattern in serum or in other samples with high protein concentration.
Purification of crude CSF ganglioside extract
Microdialysis is a very simple and reproducible method for crude CSF ganglioside extract purification, with good recovery (98%) and no selective loss of gangliosides (tab. 1). In microdialysis, the CSF ganglioside extracts were dissolved in the least possible amount of water (up to 0.1 ml), thus achieving a ganglioside concentration closely approaching the critical micellar concentrations (2) . Besides, the short time needed for dialysis (about 4 hours) also avoids any major loss of gangliosides. Such a brief dialysis is possible because the CSF samples are desalinated during the preceding procedure of ultrafiltration. 
HPTLC and quantification by scanning densitometry
A high quality chromatogram is a prerequisite for ganglioside quantification by densitometry. Using the HCl-resorcinol method for detection of lipid-bound NeuAc, individual fractions containing about 60 ng of ganglioside can be detected on HPTLC, if applied as a 6-mm line ( fig. 3) .
Linearity of the relationship between the densitometric detector response (total area) and ganglioside content in standards (Cronassial) was demonstrated up to 10 g of gangliosides. A calibration curve for quantification of total CSF gangliosides was designed within this range.
Mullin et al. (7, 8) have reported that gangliosides after HPTLC and resorcinol staining produce different densitometric detector responses per mol of NeuAc (different calibration curves), due to differences in band geometry following migration. In our "sandwich" HPTLC technique, a lower Chromatographie temperature (17-18°C) without previous saturation of the TLC chamber with solvent vapour, and linear application of the sample resulted in ganglioside bands of nearly identical size and shape, thus minimizing the factors that might interfere when quantitating individual gangliosides within a mixture.
Recovery and precision of CSF ganglioside determination
Our results revealed an overall loss of about 25% of gangliosides during various methodological steps (tab. 
CSF ganglioside pattern (HPTLC)
Lipid-bound NeuAc-positive fractions in 'normal' CSF samples were demonstrated in the following regions as defined by standards (%, mean): G M i (3.4%), G D3 (3.6%), G Dla (14.6%), X, (2.5%), G Dlb (15.6%), X 2 (3.8%), G T i b (40.6%), and G Qlb (15.9%) (tab. 3).
The CSF ganglioside profile resembled that of brain gangliosides, particularly cerebellum gangliosides, with G T i b as a predominant fraction (16) . Our results also showed G Dla to.be higher in infancy (tab. 3), which correlated well with the results obtained on brain tissue (17) . Higher proportions of G M3 and G D3 in pathological CSF ganglioside patterns correlated with the blood-brain barrier dysfunction (CSF haemorrhages, tumour processes), and suggested an increased transport of serum gangliosides into CSF. The ganglioside profile from CSF obtained by our modification did not differ from the profile produced by microdialysis (see fig. 2 ). Ganglioside fractions on HPTLC were visualized by spraying with resorcinol/HCl reagent. Bernheimer (4), Leeden & Yu (5), and Nagai et al. (6) were the first to show that the TLC profile of CSF gangliosides is similar to that of the brain. Naturally, because of methodologic difficulties, these early chromatograms were of poor quality, or lacking certain fractions.
In contrast to these results, Hirabayashi et al. (18) have shown that G M i and G D i a gangliosides predominate in CSF, using a very sensitive method of enzymeimmunostaining on the TLC plate. The reason for the absence of the polysialogangliosides from the CSF profile, may have been an inadequate procedure of ganglioside extraction (chloroform/methanol alone, without aqueous phase), leading to the loss of polar gangliosides (9); or sialidase may have acted differentially on particular types of gangliosides and converted them into the corresponding asialolipids.
Comparison of brain and CSF ganglioside patterns
Parallel elution of the gangliosides of pooled 'normal" CSF and of brain tissue from Sephadex G-25 columns showed almost identical compositions, not only of the major ganglioside fractions, but also of the fractions designated as X,, X 2 and X 3 . When a more polar solvent system for HPTLC was used, chloroformmethanol-12 mmol/ 4 ). Unidentified Xi, X 2 and X 3 could be detected in the composition of both brain and CSF gangliosides and probably corresponded to G T i a (Xi), G D2 (X 2 ) and G T3 (X 3 ).
The data presented suggest that CSF contains gangliosides that are nearly identical with typical brain gangliosides. Therefore, CSF gangliosides are probably mostly secreted from brain cells, which appears to be supported by the appearance of G M 2 ganglioside in the CSF of patients with G M 2 gangliosidosis (3).
Content of CSF gangliosides in 'normal' adults
Our results on the total content of gangliosides in ten 'normal' CSFs, i. e. 780 ± 82 μ §/1 of gangliosides (tab. 3), is comparable to that reported by Ledeen & Yu (466 -1130 μg/l) (5). The presence of contaminants (probably protein-bound NeuAc) might have been responsible for the higher ganglioside value in normal pooled CSF (1320 μg/l) reported by Nagai et al. (6) . Our method eliminates this effect, as the ganglioside extract is first chromatographed on HPTLC, then lipid-bound NeuAc is determined by densitometry. Our method can therefore be used for the follow-up and clinical evaluation of alterations in CSF gangliosides in various neurologic diseases.
